Cargando…
The consequences of COVID-19 pandemic on patients with monoclonal gammopathy–associated systemic capillary leak syndrome (Clarkson disease)
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Academy of Allergy, Asthma & Immunology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648572/ https://www.ncbi.nlm.nih.gov/pubmed/34890829 http://dx.doi.org/10.1016/j.jaip.2021.11.023 |
| _version_ | 1784610835570622464 |
|---|---|
| author | Pineton de Chambrun, Marc Moyon, Quentin Faguer, Stanislas Urbanski, Geoffrey Mathian, Alexis Zucman, Noémie Werner, Marie Luyt, Charles-Edouard Verlicchi, Franco Amoura, Zahir |
| author_facet | Pineton de Chambrun, Marc Moyon, Quentin Faguer, Stanislas Urbanski, Geoffrey Mathian, Alexis Zucman, Noémie Werner, Marie Luyt, Charles-Edouard Verlicchi, Franco Amoura, Zahir |
| author_sort | Pineton de Chambrun, Marc |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8648572 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Academy of Allergy, Asthma & Immunology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86485722021-12-07 The consequences of COVID-19 pandemic on patients with monoclonal gammopathy–associated systemic capillary leak syndrome (Clarkson disease) Pineton de Chambrun, Marc Moyon, Quentin Faguer, Stanislas Urbanski, Geoffrey Mathian, Alexis Zucman, Noémie Werner, Marie Luyt, Charles-Edouard Verlicchi, Franco Amoura, Zahir J Allergy Clin Immunol Pract Clinical Communications American Academy of Allergy, Asthma & Immunology 2022-02 2021-12-07 /pmc/articles/PMC8648572/ /pubmed/34890829 http://dx.doi.org/10.1016/j.jaip.2021.11.023 Text en © 2021 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Clinical Communications Pineton de Chambrun, Marc Moyon, Quentin Faguer, Stanislas Urbanski, Geoffrey Mathian, Alexis Zucman, Noémie Werner, Marie Luyt, Charles-Edouard Verlicchi, Franco Amoura, Zahir The consequences of COVID-19 pandemic on patients with monoclonal gammopathy–associated systemic capillary leak syndrome (Clarkson disease) |
| title | The consequences of COVID-19 pandemic on patients with monoclonal gammopathy–associated systemic capillary leak syndrome (Clarkson disease) |
| title_full | The consequences of COVID-19 pandemic on patients with monoclonal gammopathy–associated systemic capillary leak syndrome (Clarkson disease) |
| title_fullStr | The consequences of COVID-19 pandemic on patients with monoclonal gammopathy–associated systemic capillary leak syndrome (Clarkson disease) |
| title_full_unstemmed | The consequences of COVID-19 pandemic on patients with monoclonal gammopathy–associated systemic capillary leak syndrome (Clarkson disease) |
| title_short | The consequences of COVID-19 pandemic on patients with monoclonal gammopathy–associated systemic capillary leak syndrome (Clarkson disease) |
| title_sort | consequences of covid-19 pandemic on patients with monoclonal gammopathy–associated systemic capillary leak syndrome (clarkson disease) |
| topic | Clinical Communications |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648572/ https://www.ncbi.nlm.nih.gov/pubmed/34890829 http://dx.doi.org/10.1016/j.jaip.2021.11.023 |
| work_keys_str_mv | AT pinetondechambrunmarc theconsequencesofcovid19pandemiconpatientswithmonoclonalgammopathyassociatedsystemiccapillaryleaksyndromeclarksondisease AT moyonquentin theconsequencesofcovid19pandemiconpatientswithmonoclonalgammopathyassociatedsystemiccapillaryleaksyndromeclarksondisease AT faguerstanislas theconsequencesofcovid19pandemiconpatientswithmonoclonalgammopathyassociatedsystemiccapillaryleaksyndromeclarksondisease AT urbanskigeoffrey theconsequencesofcovid19pandemiconpatientswithmonoclonalgammopathyassociatedsystemiccapillaryleaksyndromeclarksondisease AT mathianalexis theconsequencesofcovid19pandemiconpatientswithmonoclonalgammopathyassociatedsystemiccapillaryleaksyndromeclarksondisease AT zucmannoemie theconsequencesofcovid19pandemiconpatientswithmonoclonalgammopathyassociatedsystemiccapillaryleaksyndromeclarksondisease AT wernermarie theconsequencesofcovid19pandemiconpatientswithmonoclonalgammopathyassociatedsystemiccapillaryleaksyndromeclarksondisease AT luytcharlesedouard theconsequencesofcovid19pandemiconpatientswithmonoclonalgammopathyassociatedsystemiccapillaryleaksyndromeclarksondisease AT verlicchifranco theconsequencesofcovid19pandemiconpatientswithmonoclonalgammopathyassociatedsystemiccapillaryleaksyndromeclarksondisease AT amourazahir theconsequencesofcovid19pandemiconpatientswithmonoclonalgammopathyassociatedsystemiccapillaryleaksyndromeclarksondisease AT theconsequencesofcovid19pandemiconpatientswithmonoclonalgammopathyassociatedsystemiccapillaryleaksyndromeclarksondisease AT pinetondechambrunmarc consequencesofcovid19pandemiconpatientswithmonoclonalgammopathyassociatedsystemiccapillaryleaksyndromeclarksondisease AT moyonquentin consequencesofcovid19pandemiconpatientswithmonoclonalgammopathyassociatedsystemiccapillaryleaksyndromeclarksondisease AT faguerstanislas consequencesofcovid19pandemiconpatientswithmonoclonalgammopathyassociatedsystemiccapillaryleaksyndromeclarksondisease AT urbanskigeoffrey consequencesofcovid19pandemiconpatientswithmonoclonalgammopathyassociatedsystemiccapillaryleaksyndromeclarksondisease AT mathianalexis consequencesofcovid19pandemiconpatientswithmonoclonalgammopathyassociatedsystemiccapillaryleaksyndromeclarksondisease AT zucmannoemie consequencesofcovid19pandemiconpatientswithmonoclonalgammopathyassociatedsystemiccapillaryleaksyndromeclarksondisease AT wernermarie consequencesofcovid19pandemiconpatientswithmonoclonalgammopathyassociatedsystemiccapillaryleaksyndromeclarksondisease AT luytcharlesedouard consequencesofcovid19pandemiconpatientswithmonoclonalgammopathyassociatedsystemiccapillaryleaksyndromeclarksondisease AT verlicchifranco consequencesofcovid19pandemiconpatientswithmonoclonalgammopathyassociatedsystemiccapillaryleaksyndromeclarksondisease AT amourazahir consequencesofcovid19pandemiconpatientswithmonoclonalgammopathyassociatedsystemiccapillaryleaksyndromeclarksondisease AT consequencesofcovid19pandemiconpatientswithmonoclonalgammopathyassociatedsystemiccapillaryleaksyndromeclarksondisease |